4Caloz C, Itoh T 2006 Electromagnetic Metamaterials: Transmission Line Theory and Microwave Applications: The Engineering Approach (New Jersey: John Wiley & Sons, Inc.) pp2,3.
5Landy N I, Sajuyigbe S, Mock J J, Smith D R, Padilla W J 2008 Phys. Rev. Lett. 100 207402.
6Schurig D, Mock J J, Justice B J, Cummer S A, Pendry J B, Starr A F, Smith D R 2006 Science 314 977.
7Tao H, Padilla W J, Zhang X, Averitt R D 2011 IEEE J. Sel. Top. Quantum Electron. 17 92.
8Tao H, Landy N I, Bingham C M, Zhang X, Averitt R D, Padilla W J 2008 Opt. Express 16 7181.
9Avitzour Y, Urzhumov Y A, Shvetset G 2009 Phys. Rev. 79 045131.
10Landy N I, Sajuyigbe S, Mock J J, Smith D R, Padilla W J 2008 Phys. Rev. Lett. 100 07402.
1Palsson R, Niles J L. Regional citrate anticoagulation in
continuous venovenous hemofiltration in critically ill patients
with a high risk of bleeding [J].Kidney Int, 1999,55(5):1991-7.
2Faber L M, De Vries P M,Oe P L,et al.Citrate hemodialysis [J].
Neth J Med, 1990,37:219-224.
3A.R.Webb, M.G.Mythen,D.Jacobson,et al.Maintaining blood flow
in the extracorporeal circuit: haemostasis and
anticoagulation[J].Intensive Care Med, 1995,21:84-93.
4Sramek V, Novak I, Mate Jovic M,et al.Continuous venovenous
hemodiafiltration (CVVHDF) with citrate anticoagulation in the
treatment of a patient with acute renal failure, hypercalcemia, and
thrombocytopenia [J].Intensive Care Med, 1998,24(3):262-4.
5Mehta R L,Mcdonald B R,Aguilar M M,et al. Regional citrate
anticoagelation for continuous arteriovenous hemodialysis in
critically ill patients [J].Kidney Int, 1990,38:976-981.
6Ahmad S,Yeo K T,Jensen W M,et al. Citrate anticoagulation
during in vivo simulation of slow hemofiltration [J].Blood
Purif,1999,8:177-182.
